搜索临床试验以:Imatinib Mesylate
总计2428个结果
-
Imperial College LondonUniversity of Sheffield; Medical Research Council; University of Cambridge; National Institute for...主动,不招人
-
Renato Melaragno暂停急性淋巴细胞白血病 (ALL) 费城染色体阳性 (Ph+)
-
Renato Melaragno未知
-
University of BolognaNovartis未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital撤销
-
Fujian Medical University Union Hospital尚未招聘
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; Southwest Oncology Group终止
-
Novartis Pharmaceuticals终止慢性粒细胞白血病 (CML) | 费城染色体阳性急性淋巴细胞白血病 (Ph+ ALL) | 其他格列卫/格列卫适应症血液学疾病(HES、CEL、MDS/MPN)俄罗斯联邦
-
Novartis Pharmaceuticals完全的
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.完全的
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital...完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI); Novartis Pharmaceuticals完全的
-
Jan BeumerNovartis Pharmaceuticals完全的
-
National Cancer Institute (NCI)完全的
-
Poitiers University HospitalNovartis; Ministry of Health, France终止
-
Goethe UniversityGerman Federal Ministry of Education and Research; Deutsche Leukämie- & Lymphom-Hilfe招聘中
-
Novartis Pharmaceuticals完全的泌尿生殖系统肿瘤 | 生殖器肿瘤,男性 | 前列腺疾病 | 抗肿瘤药 | 伊马替尼 | 前列腺肿瘤 | 生殖器疾病,男性 | 肿瘤,腹部德国